文献速递重症综合管理与镇静镇痛心脑血管急症复苏、休克与脓毒症

亚低温可能降低VA-ECMO成人患者死亡率并改善神经预后:系统评价与Meta分析

Hypothermia may reduce mortality and improve neurologic outcomes in adult patients treated with VA-ECMO: A systematic review and meta-analysis.
PubMed 文献 · Am J Emerg Med · 2023-05-26
一句话结论系统评价与Meta分析显示,VA-ECMO患者接受33-35°C亚低温至少24小时可降低短期死亡率并改善神经预后,但证据确定性较低,需谨慎对待。

该系统评价与Meta分析检索PubMed、Embase、Web of Science和Cochrane Library(截至2022年12月31日),纳入27篇文献共3782例VA-ECMO患者。主要终点为出院或28天死亡率及神经预后良好,次要终点为出血风险。结果显示,33-35°C亚低温持续至少24小时可显著降低短期死亡率(OR 0.45,95%CI 0.33-0.63,I²=41%),显著改善神经预后良好率(OR 2.08,95%CI 1.66-2.61,I²=3%),且不增加出血风险(OR 1.15,95%CI 0.86-1.53,I²=12%)。亚组分析中,院内和院外心脏骤停患者均显示死亡率降低。GRADE评估显示证据确定性相对较低,作者认为亚低温策略需谨慎对待。

要点

  • VA-ECMO患者接受33-35°C亚低温至少24小时,出院或28天死亡率显著降低(OR 0.45,95%CI 0.33-0.63,I²=41%)。
  • 亚低温组神经预后良好率显著提高(OR 2.08,95%CI 1.66-2.61,I²=3%)。
  • 亚低温不增加出血风险(OR 1.15,95%CI 0.86-1.53,I²=12%)。
  • 亚组分析显示,院内(OR 0.30,95%CI 0.11-0.86,I²=0.0%)和院外(OR 0.41,95%CI 0.25-0.69,I²=52.3%)心脏骤停患者短期死亡率均降低。
  • GRADE评估提示证据确定性相对较低,作者认为亚低温策略用于VA-ECMO患者需谨慎对待。

适用人群与场景

  • 成人VA-ECMO患者(纳入27篇文献,共3782例)
  • 亚组包括院内和院外心脏骤停接受VA-ECMO辅助的患者

处置流程与药物剂量

  • 亚低温方案为33-35°C,持续至少24小时(基于纳入研究的干预方案)。

研究设计与关键结果

  • 系统评价与Meta分析,纳入27篇文献、3782例VA-ECMO患者,检索PubMed、Embase、Web of Science和Cochrane Library(至2022年12月31日)。
  • 33-35°C亚低温持续至少24小时显著降低出院或28天死亡率(OR 0.45,95%CI 0.33-0.63,I²=41%)。
  • 亚低温显著改善神经预后良好率(OR 2.08,95%CI 1.66-2.61,I²=3%)。
  • 亚低温不增加出血风险(OR 1.15,95%CI 0.86-1.53,I²=12%)。
  • 院内获得性心脏骤停亚组:亚低温降低短期死亡率(OR 0.30,95%CI 0.11-0.86,I²=0.0%)。
  • 院外心脏骤停亚组:亚低温降低短期死亡率(OR 0.41,95%CI 0.25-0.69,I²=52.3%)。
  • 院外心脏骤停亚组:亚低温改善神经预后良好率(OR 2.10,95%CI 1.63-2.72,I²=0.5%)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,采用GRADE方法评估证据确定性。
  • GRADE评估显示证据确定性相对较低。

对床旁实践的改变

  • 作者认为,鉴于证据确定性相对较低,亚低温作为VA-ECMO辅助患者护理的策略可能需要谨慎对待。
  • 亚低温(33-35°C持续至少24小时)与短期死亡率降低和神经预后改善相关,且不增加出血风险,但证据确定性较低,临床应用需权衡。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: VA-ECMO can greatly reduce mortality in critically ill patients, and hypothermia attenuates the deleterious effects of ischemia-reperfusion injury. We aimed to study the effects of hypothermia on mortality and neurological outcomes in VA-ECMO patients.

METHODS: A systematic search of the PubMed, Embase, Web of Science, and Cochrane Library databases was performed from the earliest available date to 31 December 2022. The primary outcome was discharge or 28-day mortality and favorable neurological outcomes in VA-ECMO patients, and the secondary outcome was bleeding risk in VA-ECMO patients. The results are presented as odds ratios (ORs) and 95% confidence intervals (CIs). Based on the heterogeneity assessed by the I2 statistic, meta-analyses were performed using random or fixed-effects models. GRADE methodology was used to rate the certainty in the findings.

RESULTS: A total of 27 articles (3782 patients) were included. Hypothermia (33-35 °C) lasting at least 24 h can significantly reduce discharge or 28-day mortality (OR, 0.45; 95% CI, 0.33-0.63; I2 = 41%) and significantly improve favorable neurological outcomes (OR, 2.08; 95% CI, 1.66-2.61; I2 = 3%) in VA-ECMO patients. Additionally, there was no risk associated with bleeding (OR, 1.15; 95% CI, 0.86-1.53; I2 = 12%). In our subgroup analysis according to in-hospital or out-of-hospital cardiac arrest, hypothermia reduced short-term mortality in both VA-ECMO-assisted in-hospital (OR, 0.30; 95% CI, 0.11-0.86; I2 = 0.0%) and out-of-hospital cardiac arrest (OR, 0.41; 95% CI, 0.25-0.69; I2 = 52.3%). Out-of-hospital cardiac arrest patients assisted by VA-ECMO for favorable neurological outcomes were consistent with the conclusions of this paper (OR, 2.10; 95% CI, 1.63-2.72; I2 = 0.5%).

CONCLUSIONS: Our results show that mild hypothermia (33-35 °C) lasting at least 24 h can greatly reduce short-term mortality and significantly improve favorable short-term neurologic outcomes in VA-ECMO-assisted patients without bleeding-related risks. As the grade assessment indicated that the certainty of the evidence was relatively low, hypothermia as a strategy for VA-ECMO-assisted patient care may need to be treated with caution.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Bian W, Bian W, Li Y, et al. Hypothermia may reduce mortality and improve neurologic outcomes in adult patients treated with VA-ECMO: A systematic review and meta-analysis. Am J Emerg Med. 2023. PMID: 37327682. doi:10.1016/j.ajem.2023.05.027

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。